The Recall Desk
ModerateFDA (Devices)·Z-0539-2026·Announced 2025-11-26

Clotting time cartridges recalled over dried blood on carton labels

Medtronic is recalling 3,850 HR-ACT clotting time cartridges after trace amounts of dry blood were observed on the external carton label and instructions in five boxes.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: Scored 2 because the record describes trace contamination on outer packaging, with no stated effect on the cartridges or any reported harm.

Plain-English summary

Medtronic HR-ACT High Range Activated Clotting Time Cartridges, REF 402-03, are being recalled.

Medtronic personnel observed trace amounts of dry blood on the external carton label and the Instructions for Use in five boxes of one lot of ACT cartridges.

The recall covers 3,850 units carrying UDI/DI 20763000433844, from lot 232135734. The product was distributed in Hawaii and New York. The FDA has classified the action as Class II.

The enforcement record describes contamination on outer packaging rather than on the cartridges themselves, and states no health consequence or injuries. Laboratories holding the affected lot should follow Medtronic's instructions.

The recalled product

Product
Medtronic HR-ACT (High Range Activated Clotting Time Cartridges), REF 402-03
Affected units
3,850

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • UDI/DI 20763000433844
  • Lot Number 232135734

Distribution

Distributed nationwide across the United States.

The notice also names 2 states specifically: